|
37
|
222
|
8sdhC |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cc25.56 |
|
33
|
195
|
8sdhA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cc25.56 |
|
34
|
223
|
8xseH |
Sars-cov-2 rbd + imcas-123 + imcas-72 fab |
|
39
|
212
|
8xseL |
Sars-cov-2 rbd + imcas-123 + imcas-72 fab |
|
35
|
212
|
8xseN |
Sars-cov-2 rbd + imcas-123 + imcas-72 fab |
|
20
|
108
|
8xsiL |
Sars-cov-2 rbd + imcas-364 (local refinement) |
|
36
|
195
|
8xseA |
Sars-cov-2 rbd + imcas-123 + imcas-72 fab |
|
41
|
223
|
8xseM |
Sars-cov-2 rbd + imcas-123 + imcas-72 fab |
|
26
|
126
|
8xsiH |
Sars-cov-2 rbd + imcas-364 (local refinement) |
|
30
|
195
|
8xsiB |
Sars-cov-2 rbd + imcas-364 (local refinement) |
|
33
|
195
|
8xk2A |
A neutralizing nanobody vhh60 against wt sars-cov-2 |
|
21
|
121
|
8xk2B |
A neutralizing nanobody vhh60 against wt sars-cov-2 |
|
48
|
209
|
8qh0L |
Crystal structure of the sars-cov-2 rbd with the antibody cv2.3194 |
|
44
|
194
|
8qh0A |
Crystal structure of the sars-cov-2 rbd with the antibody cv2.3194 |
|
49
|
219
|
8qh0H |
Crystal structure of the sars-cov-2 rbd with the antibody cv2.3194 |
|
27
|
195
|
8xzdB |
The structure of fox ace2 and omicron bf.7 rbd complex |
|
194
|
596
|
8xzdA |
The structure of fox ace2 and omicron bf.7 rbd complex |
|
50
|
212
|
8x0yF |
Crystal structure of jm-1a in complex with sars-cov-2 rbd |
|
36
|
220
|
8x0xG |
Crystal structure of je-5c in complex with sars-cov-2 rbd |
|
36
|
195
|
8x0xA |
Crystal structure of je-5c in complex with sars-cov-2 rbd |
|
43
|
195
|
8x0yA |
Crystal structure of jm-1a in complex with sars-cov-2 rbd |
|
44
|
219
|
8x0yE |
Crystal structure of jm-1a in complex with sars-cov-2 rbd |
|
38
|
212
|
8x0xK |
Crystal structure of je-5c in complex with sars-cov-2 rbd |
|
32
|
195
|
8p5mI |
Sars-cov-2 spike rbd in complex with mab-23 (fab) |
|
21
|
107
|
8p5mL |
Sars-cov-2 spike rbd in complex with mab-23 (fab) |
|
27
|
117
|
8p5mG |
Sars-cov-2 spike rbd in complex with mab-23 (fab) |
|
42
|
193
|
9b82A |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cova2-15 |
|
46
|
219
|
9b82G |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cova2-15 |
|
40
|
230
|
9b82H |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cova2-15 |
|
40
|
195
|
8zerB |
Crystal structure of the complex of wuhan sars-cov-2 rbd (319-541) with p2c5 nanobody |
|
27
|
120
|
8zerA |
Crystal structure of the complex of wuhan sars-cov-2 rbd (319-541) with p2c5 nanobody |
|
34
|
194
|
8zesA |
Crystal structure of the wuhan sars-cov-2 rbd (333-541) complexed with p2c5 nanobody |
|
25
|
121
|
8zesB |
Crystal structure of the wuhan sars-cov-2 rbd (333-541) complexed with p2c5 nanobody |
|
158
|
597
|
8yf2A |
Cryo-em structure of sars-cov-2 prototype rbd in complex with raccoon dog ace2 (local refinement) |
|
17
|
194
|
8yf2B |
Cryo-em structure of sars-cov-2 prototype rbd in complex with raccoon dog ace2 (local refinement) |
|
24
|
193
|
8wsrC |
The structure of btsy1_rbd/hace2 protein |
|
52
|
232
|
8wfhE |
Crystal structure of omicron ba.4/5 in complex with a neutralizing antibody scfv d1 |
|
27
|
129
|
8wcgE |
Crystal structure of sars-cov-1 rbd in complex with nanobody asr29 and asr347 |
|
34
|
193
|
8wfhA |
Crystal structure of omicron ba.4/5 in complex with a neutralizing antibody scfv d1 |
|
39
|
195
|
8wcgA |
Crystal structure of sars-cov-1 rbd in complex with nanobody asr29 and asr347 |
|
30
|
126
|
8wcgC |
Crystal structure of sars-cov-1 rbd in complex with nanobody asr29 and asr347 |
|
17
|
109
|
8viaL |
Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by sars-cov-2 mrna vaccination |
|
40
|
386
|
8viaD |
Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by sars-cov-2 mrna vaccination |
|
84
|
355
|
8viaC |
Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by sars-cov-2 mrna vaccination |
|
22
|
124
|
8viaH |
Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by sars-cov-2 mrna vaccination |
|
33
|
223
|
8rrnC |
Crystal structure of the sars-cov-2 s rbd in complex with pt1616 fab |
|
29
|
193
|
8rrnA |
Crystal structure of the sars-cov-2 s rbd in complex with pt1616 fab |
|
35
|
213
|
8rrnD |
Crystal structure of the sars-cov-2 s rbd in complex with pt1616 fab |
|
29
|
121
|
8rj7B |
The crystal structure of the sars-cov-2 receptor binding domain in complex with the neutralizing nanobody 1.29 |
|
47
|
196
|
8rj7A |
The crystal structure of the sars-cov-2 receptor binding domain in complex with the neutralizing nanobody 1.29 |
